-
Industry Sessions
Access to the Industry Supported CME Satellite Symposia / Non-CME Presentations or Product Theaters.
*Independent Industry Supported Satellite Symposia and Non-CME Presentations are not included in the MSVirtual2020 accredited program.- Presentation Date(s): Sept 21, 2020
- Total Sessions: 12
-
PT01 - Clinical profile of a new oral treatment for patients with relapsing forms of MS
- Type: Product Theater
- Presentations: 0
This non-CME activity is provided by Bristol Myers Squibb.Speakers: Jacqueline NicholasPresented on: 9/11/2020, 08:00- Details
During this presentation, Dr Jacqueline Nicholas will discuss the primary and secondary efficacy results and key safety data from the ozanimod Phase 3 trials: SUNBEAM™ and RADIANCE™.
-
PT03 - Exploring MS and fatigue Chapter 1: The science and pathophysiology
- Type: Product Theater
- Presentations: 0
This non-CME activity is provided by Janssen Neuroscience.Speakers: Ludwig KapposPresented on: 9/11/2020, 08:00- Details
In part 1 of a 2-part series, this educational product theater will be an overview of the pathophysiology of MS and an exploration of how this may connect to MS fatigue.
-
PT04 - Exploring MS and fatigue Chapter 2: The patient perspective
- Type: Product Theater
- Presentations: 0
This non-CME activity is provided by Janssen Neuroscience.Speakers: Laura Kolaczkowski, Amy O'Donnell, Jon StrumPresented on: 9/11/2020, 08:00- Details
In part 2 of a 2-part series, this program will be an overview of MS fatigue, while also hearing the perspective of a person living with MS and highlighting the impact that MS fatigue has on patients lives.
-
PT07 - Part 1 - Cannabis: Where are we now?
- Type: Product Theater
- Presentations: 0
This non-CME activity is provided by Greenwich Biosciences, Inc.Speakers: Jennifer TriemstraPresented on: 9/11/2020, 08:00- Details
Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. This presentation will provide an overview of cannabis and cannabinoid terminology, current regulations, and web-based resources available for continued learning.
-
PT08 - Part 2 - The endocannabinoid system: Neurotransmission, cannabinoid classification, and navigating the FDA pathway
- Type: Product Theater
- Presentations: 0
This non-CME activity is provided by Greenwich Biosciences, Inc.Speakers: Kathryn NicholPresented on: 9/11/2020, 08:00- Details
This presentation will review the basic science behind the endocannabinoid system, highlight possible benefits/risks of tapping into that system therapeutically and conclude with a brief discussion of how each type of cannabinoid product might progress through FDA research.
-
PT11 - Treatment decisions and initiating patients on a new oral for relapsing forms of MS
- Type: Product Theater
- Presentations: 0
This non-CME activity is provided by Bristol Myers Squibb.Speakers: Regina BerkovichPresented on: 9/11/2020, 08:00- Details
During this presentation, Dr Regina Berkovich will review hypothetical patient scenarios and treatment considerations for the initiation of ozanimod, the first and only S1P receptor modulator for the treatment of multiple sclerosis with no first-dose observation required. Dr Berkovich will cover preinitiation and initiation steps needed to get your patients started on this once-a-day oral medication.
-
IN01 - Every journey begins with a single step: Visualizing the chronic nature of MS
- Type: Non-CME Presentation
- Presentations: 0
This non-CME activity is provided by Sanofi Genzyme.Speakers: Laura Airas, Cristina Granziera, Erik Wallstroem | Chair(s): Jiwon OhPresented on: 9/11/2020, 14:30- Details
No details provided
-
IN02 - Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Type: CME Satellite Symposia
- Presentations: 0
This CME activity is jointly provided by the Consortium of Multiple Sclerosis Centers (CMSC) and Efficient LLC. This independent Industry Supported Satellite Symposium is supported by an educational grant from Genentech, a member of the Roche Group.Speakers: Jerome De Seze, Benjamin Greenberg | Chair(s): Brian WeinshenkerPresented on: 9/11/2020, 14:30- Details
No details provided
-
IN03 - What's New in Relapsing MS? Expert Perspectives on Pathogenesis, Targeting B Cells for Treatment, and Advances in Disease-State Monitoring
- Type: CME Satellite Symposia
- Presentations: 0
This CME activity is jointly provided by Penn State College of Medicine and PeerView Institute for Medical Education (PVI). This independent Industry Supported Satellite Symposium is supported by an educational grant from EMD Serono, Inc.Speakers: Ludwig Kappos, Amit Bar-Or | Chair(s): Xavier MontalbanPresented on: 9/11/2020, 14:30- Details
No details provided
-
IN04 - COVID-19 and MS: Lessons (to be) learned from the pandemic
- Type: Non-CME Presentation
- Presentations: 0
This non-CME activity is provided by Biogen Global Medical.Speakers: Xavier Montalban, Roberto Burioni, Liesbet Peeters | Chair(s): Gavin Giovannoni, Thomas BergerPresented on: 9/12/2020, 08:00- Details
No details provided
